[Pelotherapy in ischemic heart disease]

Area of Science:

• Cardiology
• Physical Medicine and Rehabilitation
• Rheumatology

Background:

• Ischemic heart disease (IHD) and osteochondrosis often coexist, presenting complex treatment challenges.
• Pelotherapy, a form of mud therapy, is explored for its therapeutic potential in managing chronic conditions.

Purpose of the Study:

• To evaluate the immediate and long-term efficacy of pelotherapy in patients with IHD combined with osteochondrosis.
• To assess the impact of pelotherapy on clinical symptoms and objective functional parameters in IHD patients.

Main Methods:

• Eighty patients with IHD and osteochondrosis participated in the study.
• Clinical assessments, 24-hour ECG monitoring, and bicycle ergometry were used to evaluate treatment response.
• Patient outcomes were tracked over a 12-month period.

Main Results:

• Pelotherapy demonstrated a positive effect in 75-82% of IHD patients, particularly those with painless disease or functional class II angina pectoris.
• Clinical improvements were corroborated by ECG monitoring and bicycle ergometry.
• Sustained benefits were observed for 12 months in most patients with painless IHD or functional class II, but only in 15% of functional class III patients.

Conclusions:

• Pelotherapy is an effective treatment for improving symptoms and functional capacity in IHD patients with coexisting osteochondrosis, especially in milder disease stages.
• The long-term efficacy of pelotherapy is dependent on the functional class of IHD.
• Contraindications for peloid therapy are outlined, emphasizing patient safety.